Humanetics Corporation
7 clinical trials · Sponsor
◉ Watch Humanetics Corporation
| Record | Firm | Date |
|---|---|---|
| Phase 1 BIO 300 Oral Suspension (NCT06741345) | Humanetics Corporation | 2024-12-23 |
| BIO 300 Oral Powder Safety and Pharmacokinetics (NCT04650555) | Humanetics Corporation | 2020-12-08 |
| BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients (NCT04482595) | Humanetics Corporation | 2020-11-11 |
Track Humanetics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.